The S&P/All Ordinaries (Index: ^AORD) (ASX: XAO) has closed flat at 5,286.8, after early falls were reversed, thanks to strong Chinese economic data.
Still, a number of companies rocketed up on the market today. Here's our view of four of them…
Pharmaxis Ltd (ASX: PXS) jumped 25% to 12.5 cents, despite no news from the company. The biotech is developing drugs for the treatment of lung diseases such as cystic fibrosis and announced in December 2014 that it had entered a deal to commercialise Bronchitol in the US. That is pending approval, following a phase 3 clinical trial of the drug. Shares have more than doubled since that announcement.
App developer Ziptel Ltd (ASX: ZIP) climbed 13.3% to 51 cents, after the company announced today that it was seeing an "explosion of global traffic to its ZipT website". More than 1.3 million unique visitors went to the site in the past week alone, and more than 50,000 founding members have subscribed to the new service. 76 different countries were driving that traffic. Ziptel is expected to launch its ZipT comprehensive website on January 26.
Vitamins and supplements provider Blackmores Limited (ASX: BKL) gained 11.6% to $38.50, after reporting strong growth. The company says group sales for the first half ending December 31 were $206 million, up 22% compared to the previous period. Blackmores expects it to drive net profit growth of around 50% compared to last year's first half net profit, with results announced to the market on February 26.
Alexium International Group Ltd (ASX: AJX) also gained 11.6% to 72 cents, after the company announced its first significant commercial sector account. Alexium produces environmentally friendly, fire retardant chemicals, which can be used to treat clothing and various other fabrics. The company's first account is expected to generate recurring monthly revenues starting this quarter, and resulting in annual revenues of between US$1 and US$5 million. This may be one company to watch given the additional potential of its US military involvement.
